What is kneat.com inc.?
, together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.
KSIOF · Verdict
Moderate reward · elevated risk
KSIOF's standout is growth; valuation and cash flow weigh on the picture.
Based on 88% data coverage
KSIOF · Verdict
Rev +46.7% CAGR · earnings -7.8%
Weak vs peers
-21% free-cash-flow margin
-16% net margin · -2% ROE
Below average
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. The company is listed on the OTCQX in USA, operating in the Healthcare sector, with a market capitalisation of 293.06M.
The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.